How we help you invest

More

More

Why we love ETFs

Our investment expertise

Safe and secure

iShares Nasdaq US Biotechnology

(BTEK)

£4.70

Previous business day’s close price

‑£0.29 (‑5.77%)

max available period

£3.91

£5.65

04 Jan 21

29 Sep 23

Details

This ETF tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease, via the Nasdaq Biotechnology index. This ETF reinvests income.

Ticker: BTEK
ISIN: IE00BYXG2H39

Key information

Key investor information

ETF Breakdown

Region

Region

North America

UK

Europe ex-UK

Emerging Markets

Asia ex-Japan

Rest of the World

Sector

Sector

Industrial

Healthcare

Technology

Consumer

Sector ‐ Other

AMGEN Inc.

9.4%

Vertex Pharmaceuticals, Inc.

8.5%

Regeneron Pharmaceuticals, Inc.

8.4%

Gilead Sciences, Inc.

8.0%

Moderna Inc

4.1%

Astrazeneca plc

3.8%

Seagen Inc

3.7%

Biogen Inc

3.6%

Illumina Inc

2.5%

Horizon Therapeutics Plc

2.5%

Alnylam Pharmaceuticals Inc

2.3%

Biomarin Pharmaceutical Inc.

1.6%

Sanofi

1.5%

argenx SE

1.4%

Incyte Corp.

1.4%

Royalty Pharma plc

1.3%

Viatris Inc

1.2%

BioNTech SE

1.1%

Sarepta Therapeutics Inc

1.1%

Neurocrine Biosciences, Inc.

1.0%

United Therapeutics Corp

1.0%

Jazz Pharmaceuticals plc

0.9%

Myovant Sciences Ltd

0.8%

BeiGene Ltd

0.8%

Medpace Holdings Inc

0.8%

Exelixis Inc

0.7%

Karuna Therapeutics Inc

0.7%

Ionis Pharmaceuticals Inc

0.6%

Ascendis Pharma A/S

0.5%

Halozyme Therapeutics Inc.

0.5%

Reata Pharmaceuticals Inc

0.5%

Intra‑Cellular Therapies Inc

0.5%

Abcam

0.5%

Apellis Pharmaceuticals Inc

0.5%

Alkermes plc

0.5%

BridgeBio Pharma Inc

0.5%

Vaxcyte Inc

0.5%

Guardant Health Inc

0.4%

Legend Biotech Corp

0.4%

Acadia Pharmaceuticals Inc

0.4%

Syneos Health Us Inc

0.4%

Immunogen, Inc.

0.4%

CRISPR Therapeutics AG

0.4%

Amicus Therapeutics Inc

0.3%

Axsome Therapeutics Inc

0.3%

Revolution Medicines Inc

0.3%

Cytokinetics Inc

0.3%

Intellia Therapeutics Inc

0.3%

Canticle Pharmaceuticals Inc

0.3%

Denali Therapeutics Inc

0.3%

Krystal Biotech Inc

0.3%

Blueprint Medicines Corp

0.3%

Arrowhead Pharmaceuticals Inc.

0.3%

Immunovant Inc

0.3%

Insmed Inc

0.3%

PTC Therapeutics Inc

0.3%

Pacific Biosciences of California Inc

0.3%

Prothena Corporation plc

0.3%

Akero Therapeutics Inc

0.3%

Amphastar Pharmaceuticals Inc

0.3%

Ultragenyx Pharmaceutical Inc.

0.3%

Mirati Therapeutics Inc

0.2%

Morphic Holding Inc

0.2%

Xenon Pharmaceuticals Inc

0.2%

NovoCure Ltd

0.2%

Nuvalent Inc

0.2%

Harmony Biosciences Holdings Inc

0.2%

CureVac N.V.

0.2%

Ventyx Biosciences Inc

0.2%

Veracyte Inc

0.2%

Zentalis Pharmaceuticals Inc

0.2%

Arcellx Inc

0.2%

Beam Therapeutics Inc

0.2%

Immunocore Holdings plc

0.2%

Recursion Pharmaceuticals Inc

0.2%

SpringWorks Therapeutics Inc

0.2%

Genmab

0.2%

Ideaya Biosciences Inc

0.2%

Supernus Pharmaceuticals Inc

0.2%

Vir Biotechnology Inc

0.2%

AbCellera Biologics Inc

0.1%

Agios Pharmaceuticals Inc

0.1%

Pacira BioSciences Inc

0.1%

Zai Lab Limited

0.1%

Amylyx Pharmaceuticals Inc

0.1%

Arvinas Operations Inc

0.1%

Lion Biotechnologies Inc

0.1%

Myriad Genetics, Inc.

0.1%

Revance Therapeutics Inc

0.1%

Rhythm Pharmaceuticals Inc.

0.1%

Biocryst Pharmaceuticals Inc.

0.1%

Cymabay Therapeutics Inc

0.1%

Ironwood Pharmaceuticals Inc

0.1%

Maravai LifeSciences Holdings Inc

0.1%

Xencor Inc

0.1%

89bio Inc

0.1%

ANI Pharmaceuticals Inc

0.1%

Geron Corp.

0.1%

Mannkind Corp

0.1%

Merus N.V

0.1%

Relay Therapeutics Inc

0.1%

Rocket Pharmaceuticals Inc

0.1%

Syndax Pharmaceuticals Inc

0.1%

Twist Bioscience Corp

0.1%

Verona Pharma Plc

0.1%

Day One Biopharmaceuticals Inc

0.1%

EQRx Inc

0.1%

Ligand Pharmaceuticals, Inc.

0.1%

Protagonist Therapeutics Inc

0.1%

Replimune Group Inc

0.1%

Sage Therapeutics Inc

0.1%

Summit Therapeutics Inc

0.1%

Cogent Biosciences Inc

0.1%

Deciphera Pharmaceuticals Inc

0.1%

Grifols SA

0.1%

Keros Therapeutics Inc

0.1%

Kymera Therapeutics Inc

0.1%

Pliant Therapeutics Inc

0.1%

Sana Biotechnology Inc

0.1%

Travere Therapeutics Inc

0.1%

Adaptive Biotechnologies Corp

< 0.1%

Ardelyx Inc

< 0.1%

Crinetics Pharmaceuticals Inc

< 0.1%

Inhibrx Inc

< 0.1%

Mirum Pharmaceuticals Inc

< 0.1%

Adma Biologics Inc

< 0.1%

Arcturus Therapeutics Holdings Inc

< 0.1%

Avadel Pharmaceuticals plc

< 0.1%

Collegium Pharmaceutical Inc

< 0.1%

Innoviva Inc

< 0.1%

Verve Therapeutics Inc

< 0.1%

Editas Medicine Inc

< 0.1%

ImmunityBio Inc

< 0.1%

Novavax, Inc.

< 0.1%

Phathom Pharmaceuticals Inc

< 0.1%

Regenxbio Inc

< 0.1%

4D Molecular Therapeutics Inc

< 0.1%

Allogene Therapeutics Inc

< 0.1%

Alpine Immune Sciences Inc

< 0.1%

Anavex Life Sciences Corporation

< 0.1%

Biomea Fusion Inc

< 0.1%

Dyne Therapeutics Inc

< 0.1%

Evolus Inc

< 0.1%

Galapagos NV

< 0.1%

Kiniksa Pharmaceuticals Ltd

< 0.1%

Kura Oncology Inc

< 0.1%

Lyell Immunopharma Inc

< 0.1%

RAPT Therapeutics Inc

< 0.1%

Silverback Therapeutics Inc

< 0.1%

Tango Therapeutics Inc

< 0.1%

Aclaris Therapeutics Inc

< 0.1%

AnaptysBio Inc

< 0.1%

Arcutis Biotherapeutics Inc

< 0.1%

Avidity Biosciences Inc

< 0.1%

Bicycle Therapeutics Plc

< 0.1%

Castle Biosciences Inc

< 0.1%

Coherus Biosciences Inc

< 0.1%

Harrow Health Inc

< 0.1%

HilleVax Inc

< 0.1%

PetIQ Inc

< 0.1%

Tarsus Pharmaceuticals Inc

< 0.1%

Theravance Biopharma Inc

< 0.1%

UroGen Pharma Ltd

< 0.1%

Alector Inc

< 0.1%

Amarin Corp

< 0.1%

Bluebird bio Inc

< 0.1%

Caribou Biosciences Inc

< 0.1%

Centessa Pharmaceuticals plc

< 0.1%

Cullinan Oncology Inc

< 0.1%

Edgewise Therapeutics Inc

< 0.1%

Erasca Inc

< 0.1%

HUTCHMED (China) Limited

< 0.1%

Humacyte Inc

< 0.1%

ITeos Therapeutics Inc

< 0.1%

Intercept Pharmaceuticals Inc

< 0.1%

Lexicon Pharmaceuticals Inc

< 0.1%

Marinus Pharmaceuticals Inc

< 0.1%

MaxCyte Inc

< 0.1%

MeiraGTx Holdings plc

< 0.1%

Nautilus Biotechnology Inc

< 0.1%

Nurix Therapeutics Inc

< 0.1%

Precigen Inc

< 0.1%

Repare Therapeutics Inc

< 0.1%

Seres Therapeutics Inc

< 0.1%

Wave Life Sciences Ltd.

< 0.1%

uniQure N.V.

< 0.1%

23Andme Holding Class A

< 0.1%

ATAI Life Sciences N.V.

< 0.1%

Acumen Pharmaceuticals Inc

< 0.1%

AlloVir Inc

< 0.1%

Arbutus Biopharma Corp

< 0.1%

Atea Pharmaceuticals Inc

< 0.1%

Enanta Pharmaceuticals Inc

< 0.1%

Exscientia Plc

< 0.1%

Foghorn Therapeutics Inc

< 0.1%

Fulcrum Therapeutics Inc

< 0.1%

Generation Bio Co

< 0.1%

Immuneering Corp

< 0.1%

Macrogenics Inc

< 0.1%

Monte Rosa Therapeutics Inc

< 0.1%

Ocular Therapeutix Inc

< 0.1%

PMV Pharmaceuticals Inc

< 0.1%

Phibro Animal Health Corp.

< 0.1%

Quantum‑Si Incorporated

< 0.1%

SIGA Technologies Inc

< 0.1%

Scholar Rock Holding Corp

< 0.1%

Sutro Biopharma Inc

< 0.1%

Terns Pharmaceuticals Inc

< 0.1%

Vanda Pharmaceuticals Inc

< 0.1%

Xeris Biopharma Holdings Inc

< 0.1%

2seventy bio Inc

< 0.1%

Absci Corp

< 0.1%

Allakos Inc

< 0.1%

Alx Oncology Holdings Inc

< 0.1%

Compass Pathways Plc

< 0.1%

Eagle Pharmaceuticals Inc

< 0.1%

Esperion Therapeutics Inc.

< 0.1%

Fate Therapeutics Inc

< 0.1%

Gracell Biotechnologies Inc

< 0.1%

IGM Biosciences Inc

< 0.1%

Invivyd Inc

< 0.1%

Omega Therapeutics Inc

< 0.1%

Omeros Corp

< 0.1%

Poseida Therapeutics Inc

< 0.1%

Prelude Therapeutics Inc

< 0.1%

Sangamo Therapeutics Inc

< 0.1%

Selecta Biosciences Inc

< 0.1%

Stoke Therapeutics Inc

< 0.1%

21ST Century Therapeutics Inc

< 0.1%

Adaptimmune Therapeutics Plc

< 0.1%

Adicet Bio Inc

< 0.1%

Affimed N.V.

< 0.1%

Altimmune Inc

< 0.1%

Annexon Inc

< 0.1%

Atara Biotherapeutics Inc

< 0.1%

BioAtla Inc

< 0.1%

C4 Therapeutics Inc

< 0.1%

Cara Therapeutics Inc

< 0.1%

Cedexis Inc

< 0.1%

Cue Health Inc

< 0.1%

Design Therapeutics Inc

< 0.1%

Evelo Biosciences Inc

< 0.1%

FibroGen Inc

< 0.1%

G1 Therapeutics Inc

< 0.1%

Gossamer Bio Inc

< 0.1%

Graphite Bio Inc

< 0.1%

Gritstone Bio Inc

< 0.1%

I‑Mab

< 0.1%

Inovio Pharmaceuticals Inc

< 0.1%

Instil Bio Inc

< 0.1%

Karyopharm Therapeutics Inc

< 0.1%

Kezar Life Sciences Inc

< 0.1%

Kinnate Biopharma Inc

< 0.1%

Kodiak Sciences Inc

< 0.1%

Mersana Therapeutics Inc

< 0.1%

Nanostring Technologies Inc

< 0.1%

Nektar Therapeutics

< 0.1%

Ngm Biopharmaceuticals Inc

< 0.1%

Nkarta Inc

< 0.1%

OptiNose Inc

< 0.1%

PepGen Inc

< 0.1%

Others

0%

No holdings found.
Please try a different search.

North America

81.1%

Europe ex‑UK

9.1%

UK

4.7%

Emerging Markets

0.1%

Asia ex‑Japan

< 0.1%

Rest of the World

4.8%

Healthcare

57.5%

Industrial

23.8%

Technology

6.8%

Consumer

0.2%

Sector ‐ Other

11.6%

£4.70

Previous business day’s close price

Why InvestEngine

Unbeatable value

Build your own portfolio commission free or leave it to our experts for just 0.25%.
Zero ISA/account charges.
Full cost details (ETF costs apply)

Choice of 500+ ETFs

Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
View our ETF range

Actionable insights

Know exactly which companies, sectors and regions are in your portfolio.

Powerful automation

Grow your wealth the easy way with automated investing features

Easy diversification

Fractional investing lets you put as little as £1 in any ETF.

DIY or Managed

Build and manage your own portfolio or leave it to us.

Our support is available Monday-Friday 5:30am to 9:00pm
and Saturday-Sunday 8:30am to 5:30pm

Why InvestEngine

How we help you invest
Savings Plans
Our investment expertise
Safe and secure
Costs
Our ETF range
Blog
Help Centre
Сareers
Crowdfunding

ISA
General
Business

Compare

Compare with Freetrade
Compare with Hargreaves
Compare with Trading212
Compare with Roboinvesting
Compare savings
Compare fees

DIY
Managed

Legal information

Terms and conditions for clients
Using our website
Relevant regulatory information

Our Address

InvestEngine (UK) Limited, 4th Floor, 57 Great Suffolk Street, London, SE1 0BB

Why InvestEngine

Accounts

Portfolios

Compare

Legal information

Our Address

InvestEngine (UK) Limited, 4th Floor, 57 Great Suffolk Street, London, SE1 0BB

Visit our blog at blog.investengine.com

Whenever you invest, your capital is at risk

This could mean the value of your investments goes down as well as up.
Understand more about investment risk.

InvestEngine® is the trading name of InvestEngine Limited. InvestEngine (UK) Limited is Authorised and Regulated by the Financial Conduct Authority, [FRN 801128]. InvestEngine is incorporated in the UK with company number 10438231 and is registered at Lawford House, Albert Place, London, United Kingdom, N3 1QA.

InvestEngine does not provide investment advice. If you are unsure of the risk or suitability of an investment, you should seek advice from an independent financial adviser.

InvestEngine® is the trading name of InvestEngine Limited. InvestEngine (UK) Limited is Authorised and Regulated by the Financial Conduct Authority, [FRN 801128]. InvestEngine is incorporated in the UK with company number 10438231 and is registered at Lawford House, Albert Place, London, United Kingdom, N3 1QA.

© InvestEngine Limited 2023. All rights reserved.